4389 First Aid Kit

Manufacturer
Honeywell Safety Products USA, INC
Effective date
2021-12-23
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:21:14

Label at a glance#

Product4389 First Aid Kit
Active ingredientWATER, ASPIRIN, AMMONIA, BENZALKONIUM CHLORIDE, ACETAMINOPHEN, IBUPROFEN, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HYDROCHLORIDE
Label structure73 sections

Indications and uses

for flushing the eye to remove loose foreign material, air pollutants or chlorinated water

Dosage and administration

remove contacts before using twist top to remove flush the affected area as needed control rate of flow by pressure on the bottle if necessary, continue flushing with emergency eyewash or shower

Label contents#

Full prescribing information#

Eyewash Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Sterile Water 99%

Eyewash Purpose

OTC - PURPOSE SECTION

Eyewash

EyewashUses

INDICATIONS & USAGE SECTION

  • for flushing the eye to remove loose foreign material, air pollutants or chlorinated water

Eyewash Warnings

WARNINGS SECTION

For external use only Obtain immediate medical treatment for all open wounds in or near eyes. To avoid contamination, do not touch tip of container to any surface. Do not reuse. Once opened, discard.

Do not use

OTC - DO NOT USE SECTION

  • if solution changes color or becomes cloudy
  • if you have open wounds in or near the eyes, get medical help right away.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience eye pain
  • changes in vision
  • continued redness or irritation of the eye
  • condition worsens or persists

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • If swallowed, get medical help or contact a Poison Control Center right away.

Eyewash Directions

DOSAGE & ADMINISTRATION SECTION

  • remove contacts before using
  • twist top to remove
  • flush the affected area as needed
  • control rate of flow by pressure on the bottle
  • if necessary, continue flushing with emergency eyewash or shower

Eyewash Inactive ingredients

INACTIVE INGREDIENT SECTION

sodium chloride, sodium phosphate dibasic, sodium phosphate monobasic

Eyewash Questions

OTC - QUESTIONS SECTION

1-800-430-5490

Aspirin Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Aspirin 325 mg (NSAID)* *nonsteroidal anti-inflammatory drug

Aspirin Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Aspirin Uses

INDICATIONS & USAGE SECTION

temporarily reduces fever and relieves minor aches and pains associated with:

  • a cold
  • headache
  • toothache
  • muscular aches
  • backache
  • minor pain of arthritis
  • premenstrual and menstrual periods

Aspirin Warnings

WARNINGS SECTION

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Aspirin may cause a severe allergic reaction which may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:are:

  • age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Do not use

OTC - DO NOT USE SECTION

  • if you are allergic to aspirin or any other pain reliever/fever reducer

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • stomach bleeding warning applies to you
  • you have a history of stomach problems such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis or kidney disease
  • you are taking a diuretic
  • you have asthma

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • taking a prescription drug for diabetes, gout or arthritis

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
  • feel faint
  • vomit blood
  • have bloody or black stools
  • have stomach pain that does not get better
  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present in the painful area
  • ringing in the ears or loss of hearing occurs
  • any new symptoms appear

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breat-feeding, ask a health professional before use. It is especially important not to use aspirin during the last three months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • In case of overdose, get medical help or contact Poison Control Center right away.

Aspirin Directions

DOSAGE & ADMINISTRATION SECTION

  • drink a full glass of water with each dose
  • adults and children 12 years of age and older: take 1 or 2 tablets every 4 hours while symptoms last, not more than 12 tablets in 24 hours
  • children under 12 years of age: consult a doctor

Aspirin Other information

SPL UNCLASSIFIED SECTION

  • store at room temperature 15° - 30°C (59° - 86°F)
  • TAMPER EVIDIENT PACKETS
  • DO NOT USE IF OPEN OR TORN

Aspirin Inactive ingredients

INACTIVE INGREDIENT SECTION

corn starch, croscarmellose sodium*, hypromellose*, microcrystalline cellulose*, mineral oil*, polyethylene glycol*, povidone, propylene glycol, silicon dioxide, stearic acid*, titanium dioxide*

*may contain these ingredients

Aspirin Questions or Comments

OTC - QUESTIONS SECTION

1-800-430-5490

Ammonia Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Ammonia 15%

Ammonia Purpose

OTC - PURPOSE SECTION

Respiratory stimulant

Ammonia Uses

INDICATIONS & USAGE SECTION

  • to prevent or treat fainting

Ammonia Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • if you have breathing problems such as asthma or emphysema

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition persists

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • If swallowed get medical help or contact a Poison Control Center right away.

Ammonia Directions

DOSAGE & ADMINISTRATION SECTION

  • hold inhalant away from face and crush ampoule between thumb and forefinger at position indicated on sleeve.
  • hold near nostrils for inhalation of volatile vapor

Ammonia Other information

SPL UNCLASSIFIED SECTION

  • store at room temperature away from light

Ammonia Inactive ingredient

INACTIVE INGREDIENT SECTION

alcohol USP, FD&C red #40, lavender oil, lemon oil fcc, nutmeg oil, purified water

Ammonia Questions or Comments?

OTC - QUESTIONS SECTION

1-800-430-5490

BZK Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzalkonium chloride 0.13% w/v

BZK Purpose

OTC - PURPOSE SECTION

First aid antiseptic

BZK Uses

INDICATIONS & USAGE SECTION


Antiseptic cleansing of face, hands, and body without soap and water

BZK Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • in the eyes or over large areas of the body
  • on mucous membranes
  • on irritated skin
  • in case of deep puncture wounds, animal bites or serious burns, consult a doctor
  • longer than 1 week unless directed by a doctor

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • if irritation, redness or other symptoms develop
  • the condition persists or gets worse

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


If swallowed, get medical help or contact a Poison Control Center right away

BZK Directions

DOSAGE & ADMINISTRATION SECTION


tear open packet and use as a washcloth

BZK Other information

SPL UNCLASSIFIED SECTION

  • store at room temperature 15 0 to 30 0 C (5 0 - 86 0 F)
  • do not reuse towelette

BZK Inactiave ingredient

INACTIVE INGREDIENT SECTION

water

BzK Questions

OTC - QUESTIONS SECTION

1-800-430-5490

Cedaprin Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Ibuprofen 200 mg (NSAID)

*(nonsteroidal anti-inflammatory drug)

Cedaprin Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Cedaprin Uses

INDICATIONS & USAGE SECTION

temporarily relieves minor aches and pains due to:

  • headache
  • muscular aches
  • minor pain of arthritis
  • toothache
  • backache
  • the common cold
  • menstrual cramps
  • temporarily reduces fever

Cedaprin Warnings

WARNINGS SECTION

Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock
  • skin reddening
  • rash
  • blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others]
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Heart attack and stroke warning:

  • NSAID's, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

OTC - DO NOT USE SECTION

  • if you have ever had an allergic reaction to ibuprofen or any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • you have problems or serious side effectsfrom taking pain relievers or fever reducers
  • stomach bleeding warning applies to you
  • you have a history of stomach problems such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma or had a stroke
  • you are taking a diuretic

Ask a doctor or a pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • taking aspirin for heart attack or stroke, because ibuprofen may decrease the benefit of aspirin
  • under a doctors care for any serious condition
  • taking any other drug

When using this product,

OTC - WHEN USING SECTION

take with food or milk if stomach upset occursv

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
  • feel faint
  • vomit blood
  • have bloody or black stools
  • have stomach pain that does not get better
  • you have symptoms of heart problems or stroke:
  • chest pain
  • trouble breathing
  • weakness in oe part or side of body
  • slurred speech
  • leg swelling
  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present in the painful area
  • any new symptoms appear​

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away(1-800-222-1222). Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Cedaprin Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed
  • the smallest effective dose should be used
  • adult and children 12 years of age and over:
  • take 1 tablet every 4 to 6 hours while symptoms persist
  • if pain or fever does not respond to 1 tablet, 2 tablets may be used
  • do not exceed 6 tablets in 24 hours, unless directed by a doctor
  • children under 12 years: ask a doctor

Cedaprin Other information

SPL UNCLASSIFIED SECTION

  • store between 15 0 -30 0 C (59 0 -86 0 F)
  • avoid excessive heat and humidity
  • TAMPER EVIDENT PACKETS- DO NOT USE IF OPEN OR TORN

Cedaprin Inactive ingredients

INACTIVE INGREDIENT SECTION

hypromellose, lactose monohydrate, opadry II 31K, povidone K-30, ferric oxide red, silicon dioxide, starch, stearic acid, titanium dioxide, triacetin

Questions or Comments?

OTC - QUESTIONS SECTION

1-800-430-590

Burn Jel Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCl 2.0 %

Burn Jel Purpoose

OTC - PURPOSE SECTION

External analgesic

Burn Jel Uses

INDICATIONS & USAGE SECTION

temporarily relieves pain due to minor burns

Burn Jel Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on large areas of the body, particularly over raw surfaces or blistered areas

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • the condition gets worse
  • symptoms persist for more than 7 days
  • condition clears up and recurs within a few dayseas

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Burn Jel Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 2 years of age and older; apply to affected area not more than 3 to 4 times daily
  • children under 2 years of age: ask a doctor
  • you may report a serious reaction to this product to 800-430-5490

Burn Jel Other information

SPL UNCLASSIFIED SECTION

  • store at room temperature
  • do not use if opened or torn

Burn Jel Inactive ingredients

INACTIVE INGREDIENT SECTION

carbopol 940, carbopol 1342, diazolidinyl urea, glycerin, melaleuca alternifolia (tea tree) leaf oil, methylparaben, octoxynol-9, propylene glycol, propylparaben, trolamine, water ...

Burn Jel Questions

OTC - QUESTIONS SECTION

1-800-430-5490

Triple Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Bacitracin zinc 400 units

Neomycin sulfate (5 mg equivalent to 3.5 mg Neomycin base)

Polymyxin B sulfate 5000 units

Triple Purpose

OTC - PURPOSE SECTION

First aid antibiotic

First aid antibiotic

First aid antibiotic

Triple Uses

INDICATIONS & USAGE SECTION

  • first aid to help prevent infection in
  • minor cuts
  • scrapes
  • burns

Triple Warnings

WARNINGS SECTION

For external use only

Allergy alert do not use if you are allergic to any of the ingredients

Do not use

OTC - DO NOT USE SECTION

in the eyes
over large areas of the body

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • a deep or puncture wounds
  • animal bites
  • serious burnsnot use if you are allergic to any of the ingredients

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • the condition persists or gets worse
  • a rash or other allergic reaction develops
  • you need to use longer than 1 week

Keep out of the reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Triple Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the affected area
  • apply a small amount of the product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
  • may be covered with a sterile bandage

Triple Other information

SPL UNCLASSIFIED SECTION

  • store at 15 0 to 25 0 C (59 0 to 77 0 F)
  • tamper evident sealed packets
  • do not use if packet is torn or opened

Triple Inactive ingredient

INACTIVE INGREDIENT SECTION

petrolatum

Triple Questions?

OTC - QUESTIONS SECTION

1-800-430-5490

Aypanal Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen 500 mg

Aypanal Ex Purpose

OTC - PURPOSE SECTION


Pain reliever/fever reducer

Aypanal Ex Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to the common cold and headache
  • temporarily reduces fever

Aypanal Ex Warnings

WARNINGS SECTION

Liver Warning: This product contains acetaminophen. Severe liver damage may occur if you take:

  • more than 4,000 mg in 24 hours, which is the maximum daily amount.
  • with other drugs containing acetaminophen
  • adult has 3 or more alcoholic drinks every day while using this product

Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:

  • skin reddening
  • blisters
  • rash

If skin reaction occurs, stop use and seek medical help right away

Do Not Use

OTC - DO NOT USE SECTION

with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

liver disease

Ask a doctor or pharmacist before use if

OTC - ASK DOCTOR/PHARMACIST SECTION

you are taking the blood thinning drug warfarin

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present

If pregnant or breastfeeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning: In case ofl overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Aypanal Ex Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed (see overdose warning)
  • adults and children 12 years of age and over: Take 2 tablets with water every 6 hours while symptoms last.
  • do not take any more than 8 tablets in 24 hours.
  • children under 12: consult a doctor

Aypanal Ex Other information

SPL UNCLASSIFIED SECTION

  • Store at room temperature 15 0-30 0 C (59 0 -86 0 F)
  • TAMPER EVIDENT- DO NOT USE IF OPEN OR TORN

Aypanal Ex Inactive ingredients

INACTIVE INGREDIENT SECTION

microcrystalline cellulose, povidone, sodium starch glycolate, starch, stearic acid

Aypanal Ex Questions or Comments?

OTC - QUESTIONS SECTION

1-800-430-5490

4389 68P24AG KIT CONTENTS

SPL UNCLASSIFIED SECTION

1 TRIANGULAR BDG, NON-STERILE

3 INSTANT COLD PACK 4" X 6"

1 ADHESIVE BDG,PLSTIC,1"X3"16PER

1 BURN JEL 1/8 OZ, 6 PER

1 NITRILE GLOVES 2PR BBP

1 ANTIMCRBL ANTSPTC TWLETTS

1 ELASTIC BANDAGE 3" X 4.5YD

1 CPR FILTERSHIELD 77-100

1 4OZ BFS EYEWASH TRILINGUAL BOTTLE

1 SCISSOR BDGE 4" RED PLS HDL

1 KIT TWEEZER 3 1/2" SLANTED

1 BANDAGE COMP 4" W/TELFA PAD 1

LBL STOCK 6-3/8"X4"

LBL STOCK 4"X2-7/8"

1 LBL STOCK 3"x1-7/8"

1 TRIPLE BIOTIC 12 PER ZIP BAG

1 CEDAPRIN 12 PACK PER ZIP BAG

1 aspirin12 PACK PER ZIP BAG

1 KIT PP 24 UNIT FA

1 ADHS TAPE .5"X2.5YD 2

1 GAUZE PADS 3"X3" 4/BX

3 AMMONIA INHALANT, BULK

Eyewash Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EyesalineEyesaline

Aspirin Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

AspirinAspirin

Ammonia Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ammonia InhalantAmmonia Inhalant

BZK Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Antiseptic WipeAntiseptic Wipe

Cedaprin Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cedeprin grancedeprin gran

Burn Jel Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Burn JelBurn Jel

Triple Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TripleTriple

Aypanal EX Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

aypanalex labelaypanalex label

4389 Kit Label 68P24AG

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

4389 label4389 label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 65 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 53 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079129-001IBUPROFENIBUPROFEN200MGTABLET / ORAL2011-03-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2884e616aacf4f…
2026-08-18 06:07:402026-07A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-283f01610625f2…
2019-09-15 20:21 UTC2019-09A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079129-001IBUPROFEN200MGTABLET / ORAL2011-03-28f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0ec5f177-bd2d-4757-e063-6394a90a4d018f4c344f-5092-d53e-e053-2a95a90a89062024-01-12WarningsExact identifier
spl set id: 8f4c344f-5092-d53e-e053-2a95a90a8906

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.